Comparative Mixture of Non-racemic and Racemic Enantiomers of Bupivacaine in Cesarean
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the mixture of enantiomers of bupivacaine
(bupivacaine S75:R25) dos not represent inferiority efficacy and safety compare to the
racemic mixture of enantiomers of bupivacaine (bupivacaine S50:R50).
Phase:
Phase 3
Details
Lead Sponsor:
Cristália Produtos Químicos Farmacêuticos Ltda.
Collaborators:
Irmandade da Santa Casa da Misericórdia de Santos Irmandade da Santa Casa de Misericordia de Sao Paulo